Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
48.51
-0.13 (-0.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CRISPR Therapeutics AG - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
44 Public Companies Make Time's Most Influential List: Coinbase, UFC, Nintendo, Netflix And More Stocks Investors Can Buy
June 27, 2025
The 2025 TIME 100 Most Influential Companies list includes over 40 companies that investors can buy stock in.
Via
Benzinga
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
June 21, 2025
Via
The Motley Fool
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
June 20, 2025
FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research
Via
Benzinga
The FDA Shake-Up Continues, And Could Impact Genetic Medicines
June 20, 2025
Nicole Verdun and Rachael Anatol were placed on administration leave without explanation.
Via
Investor's Business Daily
Topics
Government
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
June 18, 2025
Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.
Via
Benzinga
Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday
June 17, 2025
Via
Benzinga
Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
June 17, 2025
The companies were already collaborating on a handful of cardiovascular-focused gene-editing treatments.
Via
Investor's Business Daily
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It
June 09, 2025
Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases.
Via
Benzinga
Topics
Artificial Intelligence
The Best Stocks to Invest $1,000 in Right Now
June 03, 2025
Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to bear more fruit.
Via
The Motley Fool
Topics
Government
World Trade
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
June 02, 2025
Via
The Motley Fool
Topics
Economy
5 Monster Stocks to Hold for the Next 10 Years
May 20, 2025
These companies are just starting to realize the potential in up-and-coming fields, like AI and gene editing.
Via
The Motley Fool
Topics
Artificial Intelligence
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
May 20, 2025
Via
The Motley Fool
Prediction: This Beaten-Down Stock Could Double in The Next 5 Years
May 18, 2025
Via
The Motley Fool
CRSPR Stock Could Be Ready to Deliver on Its Massive Promise
May 16, 2025
CRSPR Therapeutics has ambitious goals for its gene editing technology and may be getting ready to generate the revenue needed to deliver for shareholders
Via
MarketBeat
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?
May 14, 2025
Via
The Motley Fool
2 Biotech Stocks That Are Screaming Buys in May
May 13, 2025
Via
The Motley Fool
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
May 12, 2025
The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.
Via
The Motley Fool
3 Monster Stocks to Hold for the Next 10 Years
May 10, 2025
The planets are lining up for these three stocks' underlying companies.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
May 08, 2025
In a rising market, the iconic growth investor is adding to positions trading well below their earlier highs.
Via
The Motley Fool
Topics
Artificial Intelligence
World Trade
CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst
May 07, 2025
CRISPR reports data showing dose-dependent lipid reduction and strong safety, with plans to present full results in late 2025.
Via
Benzinga
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
May 07, 2025
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.
Via
Benzinga
These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results
May 07, 2025
Via
Benzinga
Lumentum Holdings To Rally Around 46%? Here Are 10 Top Analyst Forecasts For Wednesday
May 07, 2025
Via
Benzinga
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks
May 06, 2025
The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program.
Via
Investor's Business Daily
Topics
Government
Intellectual Property
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant
April 30, 2025
On Wednesday, April 30, 2025, Cathie Wood sold $2.65 million worth of Palantir shares through various ARK ETFs.
Via
Benzinga
2 Beaten-Down Stocks With Incredible Upside Potential
April 30, 2025
Via
The Motley Fool
5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years
April 20, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
3 Magnificent Stocks That Could Double or More by 2030
April 12, 2025
Via
The Motley Fool
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
April 11, 2025
Via
The Motley Fool
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
April 07, 2025
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.